Your browser doesn't support javascript.
loading
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.
Whittle, Sarah B; Offer, Katharine; Roberts, Ryan D; LeBlanc, Amy; London, Cheryl; Majzner, Robbie G; Huang, Alex Y; Houghton, Peter; Alejandro Sweet Cordero, E; Grohar, Patrick J; Isakoff, Michael; Bishop, Michael W; Stewart, Elizabeth; Slotkin, Emily K; Greengard, Emily; Borinstein, Scott C; Navid, Fariba; Gorlick, Richard; Janeway, Katherine A; Reed, Damon R; Hingorani, Pooja.
Affiliation
  • Whittle SB; Texas Children's Cancer and Hematology Centers, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Offer K; Joseph M. Sanzari Children's Hospital, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • Roberts RD; Center for Childhood Cancer and Blood Disease, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • LeBlanc A; Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • London C; Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, USA.
  • Majzner RG; Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.
  • Huang AY; Case Western Reserve University School of Medicine and UH Rainbow Babies & Children's Hospital, Cleveland, Ohio, USA.
  • Houghton P; Greehy Children's Cancer Research Institute, UT Health San Antonio, San Antonio, Texas, USA.
  • Alejandro Sweet Cordero E; Benioff Children's Hospitals, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
  • Grohar PJ; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Isakoff M; Center for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, Connecticut, USA.
  • Bishop MW; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Stewart E; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Slotkin EK; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Greengard E; University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA.
  • Borinstein SC; Department of Pediatrics, Division of Pediatric Hematology Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Navid F; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA.
  • Gorlick R; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Reed DR; Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
  • Hingorani P; Moffitt Cancer Center Department of Individualized Cancer Management, Tampa, Florida, USA.
Pediatr Blood Cancer ; 68(9): e29188, 2021 09.
Article in En | MEDLINE | ID: mdl-34137164
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma Type of study: Prognostic_studies Limits: Adult / Child / Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma Type of study: Prognostic_studies Limits: Adult / Child / Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Document type: Article Affiliation country: Country of publication: